The new statement emphasizes four issues: organization of newborn screening programs for PKU and CH; biologic adequacy of the blood sample and how it may influence the rate of false-negative results, and the need for routine rescreening; performance of the screening method and how it may influence the frequency of false-negative test results; and disorders of tetrahydrobiopterin homeostasis and their significance for diagnosis and treatment of infants with positive PKU tests.
|Original language||English (US)|
|Number of pages||3|
|State||Published - Jan 1 1982|
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health